BioSpace News Archive

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors.

Transparency Market Research delivers key insights on the global hygienic diaphragm valves in biopharma market.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

Microalgae cultivation start-up Yemoja Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation and Inflammatory Bowel Disease.

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that management will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 9:30 a.m. PT / 12:30 p.m. ET.

Visby Medical™ announced that it has received a 510 clearance and was granted a waiver under the Clinical Laboratory Improvement Amendments of 1988 from the US Food and Drug Administration to market its fast, single-use polymerase chain reaction diagnostic test for the multiplexed detection of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis, using a self-collected vaginal swab.

Lahey Hospital & Medical Center (LHMC) and Sarasota Interventional Radiology (SIR) participated in trial to evaluate safety and accuracy of percutaneous procedures in the lung using the XACT ACE™ Robotic System for instrument insertion.

AVEO Oncology announced that members of its senior management team will participate in two upcoming virtual investor conferences.

Gemini Therapeutics, Inc., a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration, announced that Chief Executive Officer, Jason Meyenburg, and Chief Medical Officer, Samuel Barone, M.D., presented in panel discussions at the Clinical Trials at the Summit on August 28, 2021.

Heat Biologics, Inc. today announced CEO Jeff Wolf will host a conference call on Thursday, September 2 nd at 11:00 A.M. Eastern Time to provide an update on the Company’s activities.